Alport Syndrome Market Driven by Gene Therapy Advances
Alport Syndrome Market products primarily include novel gene therapies, diagnostic assays, and supportive renal treatments designed to address the genetic mutations underlying this rare inherited kidney disorder. Gene-editing approaches such as CRISPR/Cas9 and antisense oligonucleotides offer precision correction of COL4A3, COL4A4, and COL4A5 gene defects, delivering targeted intervention that...
0 التعليقات 0 المشاركات 19 مشاهدة 0 معاينة